Cargando…
Is Intravesical Bacillus Calmette-Guérin Therapy Superior to Chemotherapy for Intermediate-risk Non-muscle-invasive Bladder Cancer?: An Ongoing Debate
The objective of this study was to evaluate the risk of recurrence in patients with intermediate-risk non-muscle-invasive bladder cancer (NMIBC) after intravesical instillation with chemotherapeutic agents or Bacillus Calmette-Guérin (BCG) therapy. A cohort of 746 patients with intermediate-risk NMI...
Autores principales: | Han, Kyung-Sik, You, Dalsan, Jeong, In Gab, Kwon, Teakmin, Hong, Bumsik, Hong, Jun Hyuk, Ahn, Hanjong, Ahn, Tai Young, Kim, Choung-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330478/ https://www.ncbi.nlm.nih.gov/pubmed/25729246 http://dx.doi.org/10.3346/jkms.2015.30.3.252 |
Ejemplares similares
-
Is Bladder Tumor Location Associated with Prostate Cancer Detection after Intravesical Bacillus Calmette-Guérin Instillation?
por: Hong, Sungwoo, et al.
Publicado: (2014) -
Managing the adverse events of intravesical bacillus Calmette–Guérin therapy
por: Decaestecker, Karel, et al.
Publicado: (2015) -
Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy
por: Minakata, Tomokazu, et al.
Publicado: (2020) -
Reactive Arthritis After Intravesical Bacillus Calmette-Guérin Therapy
por: Taniguchi, Yoshinori, et al.
Publicado: (2022) -
Long-Term Oncologic Outcomes after Radical Cystectomy for Bladder Cancer at a Single Institution
por: Kwon, Taekmin, et al.
Publicado: (2014)